These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37981168)

  • 1. The effect of diagnosis delay in testis cancer on tumor size, tumor stage and tumor markers.
    Gercek O; Topal K; Yildiz AK; Ulusoy K; Yazar VM
    Actas Urol Esp (Engl Ed); 2024 Jun; 48(5):356-363. PubMed ID: 37981168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the Significance of Rete Testis Invasion by Malign Germ Cell Tumor and Does Hilum Predict Metastasis?
    Ediz C; Ihvan A
    Urol Int; 2019; 103(1):49-54. PubMed ID: 31203276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
    Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
    Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours?
    Imamoglu GI; Eren T; Baylan B; Karacın C
    Urol Int; 2019; 103(3):303-310. PubMed ID: 31466076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Testicular Neuroendocrine Tumor Coexisting With Seminoma Sharing Germ Cell Origin.
    Iida N; Takemura K; Ito M; Funata N; Yonese I; Suzuki H; Tsuzuki T; Koga F
    Int J Surg Pathol; 2021 Dec; 29(8):887-891. PubMed ID: 33847540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers).
    Oldenburg J; Horwich A;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv165-iv166. PubMed ID: 28881930
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing incidence and delay of testicular cancer in southern Norway (1981-1992).
    Hernes EH; Harstad K; Fosså
    Eur Urol; 1996; 30(3):349-57. PubMed ID: 8931969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.
    Gallegos I; Valdevenito JP; Miranda R; Fernandez C
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):147-52. PubMed ID: 20881837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of neutrophil to lymphocyte ratio with testicular cancer.
    Ilktac A; Dogan B; Ersoz C; Akcay M; Akbulut H
    Int Braz J Urol; 2020; 46(1):101-107. PubMed ID: 31851466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decades.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Urol Oncol; 2014 Jan; 32(1):43.e17-22. PubMed ID: 23911683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular Tumor Markers in the Spermatic Vein - Correlation to Pathology, Stage and Outcome.
    Banner A; Lotterstätter M; Madersbacher S; Schauer I
    Urology; 2021 Aug; 154():196-200. PubMed ID: 33878332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers and
    Dondi F; Albano D; Bertagna F; Giubbini R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):287-292. PubMed ID: 34425969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.